Shorla Oncology Announces U.S. FDA Approval of Nelarabine Injection for the Treatment of T-Cell Leukemia March 9th 2023 Read More
We were delighted to have been a presenting company at the BIOTECH Showcase 2023 in San Francisco recently! January 16th 2023 Read More
Join Shorla Oncology at the BIO CEO and Investor Conference 2023 January 17th 2023January 16th 2023 Read More
Our CEO part of the “Cancer Across Borders – Ireland’s Reach” Panel Discussion December 12th 2022 Read More
Our CTO spoke on the founders panel at Scale Ireland’s Annual Event October 5th 2022September 12th 2022 Read More
